


Healthcare News Roundup: Ophthalmology
HSMN NewsFeed - 10 May 2007
Synergetics USA, Inc. Announces the Launch of the Largest Line of 23 Gauge Retinal Surgical Instruments
Synergetics USA, Inc. Announces the Launch of the Largest Line of 23 Gauge Retinal Surgical Instruments
HSMN NewsFeed - 3 May 2007
Synergetics USA Announces First One Step(TM) Chandelier for Retina Surgery
Synergetics USA Announces First One Step(TM) Chandelier for Retina Surgery
HSMN NewsFeed - 30 Apr 2007
Carl Zeiss Meditec: Benchmark for Eye Disease Treatment -- Company Ships 15,000th Ophthalmic Laser Worldwide
Carl Zeiss Meditec: Benchmark for Eye Disease Treatment -- Company Ships 15,000th Ophthalmic Laser Worldwide
HSMN NewsFeed - 30 Apr 2007
RegeneRx Cleared to Initiate First Ophthalmic Phase 2 Clinical Trial in Diabetics Undergoing Eye Surgery
RegeneRx Cleared to Initiate First Ophthalmic Phase 2 Clinical Trial in Diabetics Undergoing Eye Surgery
HSMN NewsFeed - 30 Apr 2007
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
HSMN NewsFeed - 27 Apr 2007
Advanced Medical Optics Launches WhiteStar Signature(TM) Phacoemulsification System with Fusion(TM) Fluidics
Advanced Medical Optics Launches WhiteStar Signature(TM) Phacoemulsification System with Fusion(TM) Fluidics
HSMN NewsFeed - 17 Apr 2007
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
HSMN NewsFeed - 17 Apr 2007
WaveLight Receives Wavefront-Guided and Mixed Astigmatism Approval for ALLEGRETTO WAVE(R) Eye-Q
WaveLight Receives Wavefront-Guided and Mixed Astigmatism Approval for ALLEGRETTO WAVE(R) Eye-Q
HSMN NewsFeed - 16 Apr 2007
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
HSMN NewsFeed - 4 Apr 2007
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
HSMN NewsFeed - 2 Apr 2007
ForSight Labs, LLC Announces New CEO Appointment and the Series A Funding of a Second Company
ForSight Labs, LLC Announces New CEO Appointment and the Series A Funding of a Second Company
